Resistance to third-generation cephalosporins in non-typhoidal Salmonella (NTS) is emerging worldwide. We report the occurrence of extended-spectrum beta-lactamase (ESBL) phenotypes in 53.4 % of NTS isolated over a period of nine years from gastroenteritis cases. ESBL and AmpC co-production was observed in 21 % of the isolates. Occurrence of bla CTX-M-15 and bla CMY-2 resistance genes was observed in 11.6 % and 37 % of the isolates respectively. Overall, Salmonella enterica serovar Senftenberg was the predominant serovar carrying bla CTX-M-15 and bla CMY-2 resistance genes. We report for the first time from India, one isolate each of S. enterica serovar Thompson, S. enterica serovar Infantis and S. enterica serovar Newport, carrying the bla CTX-M-15 gene. We also report for the first time from India, a case of gastroenteritis due to S. enterica serovar Thompson.
INTRODUCTION
Non-typhoidal Salmonella (NTS) serovars are zoonotic agents having a wide range of animal reservoirs. Infections due to NTS range from mild diarrhoeal disease to severe systemic infections. Salmonella diarrhoea is generally selflimiting and antimicrobial therapy is not recommended. However, antimicrobial agents play a critical role in the management of Salmonella infections at extremes of age, in immunocompromised patients and in systemic invasive diseases (Parry, 2003) . The current recommendations for antimicrobial therapy for Salmonella infections include extended-spectrum cephalosporins and fluoroquinolones (Angulo et al., 2000) . However, the recent emergence of antimicrobial resistance to these antimicrobials has challenged the management of salmonellosis (Piddock, 2002; Whichard et al., 2007) . Salmonella serovars resistant to extended-spectrum cephalosporins have become a global problem since the 1980s with reports from Europe, North and South America, North and Western Africa and Asian countries (Miriagou et al., 2004) . Reports of extendedspectrum beta-lactamase (ESBL)-producing Salmonella from developing countries like Pakistan and India are few, but the available reports show high rates of ESBL production, ranging from 20-42 % (Jabeen et al., 2010; Menezes et al., 2010; Uma et al., 2010) . Although limited data are available from India, the presence of resistance genes encoding ESBL and AmpC b-lactamases in Salmonella has been documented (Menezes et al., 2010) . TEM, SHV, CTXM and OXA are the ESBLs frequently observed in Salmonella serovars in Europe and the USA (Gniadkowski, 2001) . The clinical significance of CTXM enzymes that preferentially hydrolyse cefotaxime and ceftriaxone has increased significantly in the last decade (Miriagou et al., 2004) . Another enzyme which is emerging as a significant resistance factor in these serovars is an AmpC b-lactamase encoded by a self-transferable plasmid gene, bla CMY , that mediates resistance to other b-lactams, streptomycin, chloramphenicol, tetracycline and sulphonamides (Miriagou et al., 2004) . Here, we report the serotype distribution, antimicrobial resistance and molecular characterization of resistance genes encoding ESBLs and AmpC b-lactamases in NTS serovars, isolated from acute gastroenteritis cases over a period of nine years at the Postgraduate Institute of Medical Education and Research, Chandigarh, a tertiary care centre catering for a large population in North India. Research, Chandigarh, India, a tertiary care referral centre which receives patients from different parts of North India (mainly from the union territory of Chandigarh, but also from six other states, viz. Punjab, Haryana, Himachal Pradesh, Western parts of Uttar Pradesh, Jammu and Kashmir, and some parts of Rajasthan). Stool specimens of patients suffering from diarrhoea/dysentery admitted to the wards or presenting at the outpatient departments were received by the Enteric Laboratory from 2002-2010. A total of 77 Salmonella strains were isolated during this period, out of which 56 isolates were available in the culture collection. All the strains were revived from trypticase soy broth with glycerol, stored at 270 uC.
Specimen collection, transport, processing and identification.
The faecal specimens were collected in Cary-Blair medium and transported to the laboratory. Primary inoculation was carried out on MacConkey agar and xylose lysine deoxycholate agar; enrichment was performed in selenite F broth which was subcultured after 6 h (Himedia Laboratories). Non-lactose-fermenting colonies from MacConkey agar plates, and pink colonies with a black centre from xylose lysine deoxycholate agar plates were collected and subjected to further analysis by biochemical tests for the identification and isolation of possible Salmonella colonies. Isolates were then confirmed by serotyping. Isolates that were identified as Salmonella spp. were stored at room temperature in 0.5 % nutrient agar and at 270 uC in trypticase soy broth with 15 % glycerol for further studies.
Bacterial strains. A total of 77 Salmonella strains were isolated during this period, out of which 64 were NTS, 12 were Typhi and one was Paratyphi A. Out of 64 NTS, only 43 were available in the culture collection; these were taken up for the study. The isolates were retested biochemically and serotyping was done using O-and Hspecific antisera as per the Kauffman-White scheme (Grimont & Weill, 2007) . Serotypes were further confirmed at The National Salmonella and Escherichia Serotyping Centre, Central Research Institute, Kasauli, India.
Susceptibility and MIC testing. Antibiotic susceptibility was determined by the Kirby-Bauer disc diffusion method (Himedia Laboratories) against the following antibiotics: amoxicillin (30 mg), cefotaxime (30 mg), gentamicin (10 mg), amikacin (30 mg), norfloxacin (10 mg), ciprofloxacin (10 mg), chloramphenicol (30 mg), nalidixic acid (30 mg), furazolidine (100 mg) and co-trimoxazole ( ESBL and AmpC detection. Isolates were tested for ESBL production as per the CLSI guidelines, using the disc potentiation method for cefotaxime and ceftazidime, along with discs to which clavulanic acid had been added. AmpC detection was performed by the EDTA disc method, as described by Black et al. (2005) .
Genotypic methods. All the isolates were subjected to PCR to identify the presence of the following antibiotic resistance genes: bla TEM , bla OXA , bla CTX-M-15 , bla SHV and bla CMY-2 . PCR was performed in a final volume of 50 ml in 0.2 ml thin-walled tubes. The primers used for PCR amplification are listed in Table 1 . Each reaction contained 20 mM Tris/HCl (pH 8.4), 50 mM KCl, 0.2 mM each of the three deoxynucleoside triphosphates, 1.5 mM MgCl 2 , 0.6 mM primer pairs and 1.25 U of DNA Taq polymerase. The PCR protocol consisted of an initial denaturation step at 94 uC for 3 min followed by 25 cycles of DNA denaturation at 94 uC for 30 s, with primer annealing for bla TEM and bla OXA at 55 uC, for bla CTX-M-15 at 64 uC, for bla SHV at 59 uC and for bla CMY-2 at 58 uC for 30s, and primer extension at 72 uC for 1 min. After the last cycle, a final extension step at 72 uC for 7 min was added. Aliquots of PCR products (5 ml) were analysed by gel electrophoresis on agarose gels (2 % w/v). Gels were stained with ethidium bromide (10 mg ml 21 ) and visualized by UV trans-illumination. A 100 bp DNA ladder was used as a marker. Each PCR was performed with appropriate positive and negative controls.
RESULTS
During the period 2002-2010, faecal samples from 7813 patients were processed for enteric pathogens. Out of these, 77 yielded Salmonella serovars of which 64 were NTS. The majority of NTS-positive patients were adults (48/ 64575 %), while children accounted for 25 % (16/64). The male to female ratio was 2 : 1 and the ward to outpatient ratio was 2 : 1. Clinical features were available for 59 (92 %) of these patients of which 23.7 % (14/59) presented with acute gastroenteritis or loose stools. Cholera-like watery diarrhoea was observed in 13.5 % (8/ 59) patients. Dysentery was the presenting feature in 6.7 % (4/59) of the patients and chronic or recurrent diarrhoea Table 1 . List of primers used in the study to detect antimicrobial resistance genes in NTS spp. (Fig. 2) .
Results of phenotypic assays
Antimicrobial resistance. Sensitivity to all antibiotics was observed in 23 % of isolates, whereas 52 % showed resistance to one or two classes of drugs. Multidrug resistance (to three or more classes of drugs) was observed Cholera-like watery diarrhoea (8) Chronic diarrhoea (6) Colitis (5) Malignancy with diarrhoea (5) Post-renal transplant (4) Dysentery (4) Medical check-up (2) Jaundice (2) Head injury (2) Others ( N. Taneja and others in 25 % of isolates. Overall resistance rates of 77 %, 58 % and 33 % were noted for nalidixic acid, amoxicillin and cotrimoxazole respectively. Among the other quinolones, 35 % of strains were resistant to norfloxacin and 23.5 % were resistant to ciprofloxacin. The majority of the isolates were sensitive to chloramphenicol (84 %), furazolidine (77 %) and amikacin (70 %) ( Table 2 ).
The MIC values of 43 isolates tested with the Etest are shown in Fig. 3 . The MIC 50 values for ciprofloxacin, cefepime, cefotaxime and azithromycin were 0.25, 0.064, 0.125 and 4 mg ml 21 respectively, while MIC 90 values were 32, 128, 256 and 12 mg ml 21 respectively. Three isolates (6.9 %) had an MIC .16 mg ml 21 (the epidemiological cut-off) for azithromycin. One isolate of S. Senftenberg with an MIC of 256 mg ml 21 for azithromycin also showed higher MICs for ciprofloxacin, cefepime and cefotaxime, while one isolate of S. Typhimurium and one of S. Infantis showed lower MICs for cefotaxime and cefepime, but reduced susceptibility to ciprofloxacin (0.125 mg ml 21 ).
The CLSI confirmatory test for ESBL production revealed that 53.4 % (23/43) of the isolates were ESBL producers, and among these, 39 % (9/23) co-produced AmpC blactamases. Among the ESBL producers, 10 isolates (43 %) belonged to serovar S. Senftenberg. Other serovars that produced ESBL were S. Enteritidis (n53), S. Muenchen, S. Typhimurium and S. Newport (n52 each), S. Infantis, S. Richmondi, S. Thompson, Salmonella C1 and Salmonella spp. (n51 each). Out of the nine AmpC producers, eight isolates were S. Senftenberg and one was S. Newport.
Results of genotypic tests
The genes bla TEM and bla OXA were sequenced and found to be bla TEM-1 and bla OXA-1. PCR screening showed that 37 % (16/43) of these isolates were positive for the bla CMY-2 gene out of which nine (56.2 %) showed phenotypic AmpC production, whereas seven (43.7 %) did not show phenotypic AmpC production. Occurrence of the bla CMY-2 gene was highest amongst S. Senftenberg (68.7 %; 11/16), followed by S. Typhimurium and S. Enteritidis (12.5 %; 2/16 each) and S. Newport (6.2 %; 1/16). Other b-lactamase genes such as bla CTX-M-15 , bla TEM-1 and bla OXA-1 were detected in 11.6 % (5/43), 25.5 % (11/43) and 2.3 % (1/43) of the isolates, respectively. Occurrence of bla SHV was not noted in any of the Salmonella serovars tested (Table 3) . The occurrence of bla CTX-M-15 was highest amongst S. Senftenberg (3/5), followed by S. Newport and S. Infantis (one each). In 23 ESBL-producing isolates, bla CTX-M-15 was present in five, bla CMY-2 in 13, bla TEM-1 in eight and bla OXA-1 in one isolate.
DISCUSSION
This geographical region of India is a major poultry farming area. The current study was conducted over a period of nine years. At our institute, being a referral Table 2 . A, amoxicillin; CE, cefotaxime; G, gentamicin; AK, amikacin; NOR, norfloxacin; CIP, ciprofloxacin; CH, chloramphenicol; NA, nalidixic acid; FX, furazolidine; CO, co-trimoxazole; R, resistant; I, intermediate susceptibility.
Antimicrobial resistance in non-typhoidal Salmonella centre, only severe cases present, as reflected from the ward to outpatient department ratio. Nearly two-thirds of the patients were admitted, out of which eight had cholera-like watery diarrhoea. Mainly adults (72 %) were found to be affected, whereas in previous years, children under five years of age constituted nearly 90 % of all Salmonella gastrointestinal infections (Gupta et al., 1999) . A decrease in Salmonella isolation from 3.9 % in 1994-1998 (Gupta et al., 1999 ) to 1.0 % was noted, which may be due to improved hygiene practices in poultry farming.
We also noted a shift in the predominant serovar from S. Typhimurium (99/138, 77 %) in 1999 (Gupta et al., 1999) to S. Senftenberg (12/43, 28 %). Rare serovars like S. Muenchen, S. Thompson, S. Newport and S. Richmondi were also isolated in the present study, which could be due to global travel and development of immunity to circulating serovars. S. Thompson has not been reported to date in human cases from India. An isolated report of S. Newport from stool samples is available from Goa, India (Verenkar et al., 1992) . S. Newport, S. Muenchen, and S. Thompson are, respectively, the third, eighth and fifteenth most commonly reported NTS in the National Antimicrobial Resistance Monitoring System data (Zhao et al., 2009) .
In contrast to S. Senftenberg, the newer serovars, except S. Newport, were relatively more susceptible to antimicrobial agents. Compared with the previous study from our centre, S. Senftenberg showed significantly increased resistance to ciprofloxacin (51 % compared with 100 %; P50.005). However, a significant decrease in resistance to chloramphenicol (82.8 % compared with 34 %; P50.002), cotrimoxazole (94.2 % compared with 50 %; P50.001) and furazolidine (58 % compared to 88.5 %; P50.03) was observed (Gupta et al., 1999) , probably due to a decrease in clinical usage of these antibiotics. Ciprofloxacin resistance was also noted in other isolates (25 % of S. Enteritidis and S. Newport, and 33 % of S. Muenchen). However, none of the S. Typhimurium isolates was resistant to ciprofloxacin. Two out of four S. Newport isolates were multidrug resistant, also showing resistance to third-and fourthgeneration cephalosporins. The multidrug-resistant S. Newport first appeared in 1998 in the USA, and is frequently isolated from both humans and food animals sporadically as well as in outbreaks (Devasia et al., 2005; Dunne et al., 2000; Zhao et al., 2001) . In vitro studies have shown that azithromycin is a good agent for clinical management of salmonellosis. In a Finnish study, in vitro activity of azithromycin against 1237 NTS isolates was measured between 2003 and 2008; resistance to azithromycin was observed in 1.9 % of all isolates tested and 5.1 % of the isolates showing reduced susceptibility to fluoroquinolones (Gunell et al., 2010 ESBL production in Salmonella serovars ranges from 0.8 % to 3.4 % (Dunne et al., 2000; Li et al., 2005; Su et al., 2005; Winokur et al., 2001) .We observed a high frequency of ESBL phenotypes (53.4 %) among Salmonella serovars from our region, which was similar to reports (48 %) from Southern India (Menezes et al., 2010) . CTXM-producing Salmonellae were first noticed in 1989 in Argentina, and by 2004 were sporadically reported from 43 countries encompassing Europe, Latin America, the USA, Taiwan and Western Pacific (Arlet et al., 2006) . High frequencies of CTXM-15 production have been reported in S. Typhimurium, S. Infantis and S. Agona serovars (Rotimi et al., 2008) . Reports regarding bla CTX-M-15 in NTS isolates from India are scanty but include a report of one isolate of S. Typhimurium from Bangalore and also from Pondicherry in Southern India (Menezes et al., 2010) . In the current study, bla CTX-M-15 was found in 11.6 % of Salmonella serovars. The most predominant serovar carrying the bla CTX-M-15 gene was (Szych et al., 2005) . Currently, third-generation cephalosporins are the drugs of choice for treatment of severe salmonellosis. bla CTX-M-15 is a plasmid-borne gene notorious for being spread amongst bacteria, which may limit future therapeutic options.
AmpC b-lactamase phenotypes were observed in 20.9 % (9/ 43) isolates, with S. Senftenberg being the predominant serovar carrying the bla CMY-2 gene. One out of four S. Newport isolates was an AmpC-producing phenotype, carrying the bla CMY-2 gene. The first Salmonella reported carrying bla CMY-2 was S. Senftenberg which was isolated from an Algerian child in the late 1990s (Koeck et al., 1997) . Subsequent epidemiological studies have also demonstrated the wide occurrence of bla CMY-2 -producing Salmonella strains isolated from livestock and human infections (Frye & Fedorka-Cray, 2007) . All the AmpC producers in the current study had the bla CMY-2 gene. However, seven isolates carrying the bla CMY-2 gene did not show phenotypic AmpC production. The mean MIC of isolates which were positive for both AmpC and bla CMY-2 was higher than that of the isolates possessing the bla CMY-2 gene but which were negative for AmpC production (P50.039 for cefotaxime; P50.034 for cefepime). Similarly, in the USA, 8/20 Salmonella isolates from human and animal sources carrying the bla CMY-2 gene had no altered antimicrobial susceptibility pattern, suggesting silent gene carriage (Heider et al., 2009) . Strains with plasmid-mediated AmpC enzymes are generally sensitive to cefepime, as the enzyme has low activity against this antibiotic. However, in the presence of hyperproduction of class C chromosomal AmpC enzymes or upregulated efflux pumps, isolates may become resistant to cefepime (Endimiani et al., 2008) . In our study, five out of nine AmpC-producing Salmonella isolates were resistant to cefepime, which may limit future therapeutic options. Similarly, co-occurrence of plasmid-mediated AmpC and ESBL may pose problems during treatment, as these enzymes can hydrolyse even carbapenems if there is an additional porin mutation, as previously seen in Klebsiella spp. (Jacoby et al., 2004) . The major limitation of our study is the small number of isolates. It would be interesting to study the serovar distribution, antibiotic usage and resistance pattern in the NTS isolated from poultry in our region.
